BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 8841474)

  • 1. Comparison of the standard and reduced pH Syrian hamster embryo (SHE) cell in vitro transformation assays in predicting the carcinogenic potential of chemicals.
    Isfort RJ; Kerckaert GA; LeBoeuf RA
    Mutat Res; 1996 Sep; 356(1):11-63. PubMed ID: 8841474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pH 6.7 Syrian hamster embryo cell transformation assay for assessing the carcinogenic potential of chemicals.
    LeBoeuf RA; Kerckaert GA; Aardema MJ; Gibson DP; Brauninger R; Isfort RJ
    Mutat Res; 1996 Sep; 356(1):85-127. PubMed ID: 8841476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The syrian hamster embryo (SHE) cell transformation assay: review of the methods and results.
    Mauthe RJ; Gibson DP; Bunch RT; Custer L
    Toxicol Pathol; 2001; 29 Suppl():138-46. PubMed ID: 11695550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The low pH Syrian hamster embryo (SHE) cell transformation assay: a revitalized role in carcinogen prediction.
    Aardema MJ; Isfort RJ; Thompson ED; LeBoeuf RA
    Mutat Res; 1996 Sep; 356(1):5-9. PubMed ID: 8841473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the Syrian hamster embryo (SHE) cell transformation assay for predicting the carcinogenic potential of chemicals. Introduction.
    Yamasaki H
    Mutat Res; 1996 Sep; 356(1):1-3. PubMed ID: 8841472
    [No Abstract]   [Full Text] [Related]  

  • 6. An interlaboratory comparison of enhanced morphological transformation of Syrian hamster embryo cells cultured under conditions of reduced bicarbonate concentration and pH.
    LeBoeuf RA; Kerckaert GA; Poiley JA; Raineri R
    Mutat Res; 1989 Mar; 222(3):205-18. PubMed ID: 2537927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The testing of chemicals in the Syrian hamster embryo (SHE) cell transformation assay for assessment of carcinogenic potential.
    Engelhardt G; Schwind KR; Mussler B
    Toxicol In Vitro; 2004 Apr; 18(2):213-8. PubMed ID: 14757112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the Syrian hamster embryo cell transformation assay for carcinogenicity prediction of chemicals currently being tested by the National Toxicology Program in rodent bioassays.
    Kerckaert GA; Brauninger R; LeBoeuf RA; Isfort RJ
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):1075-84. PubMed ID: 8933057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the morphological transformation of Syrian hamster embryo (SHE) cells by reducing incubation time of the target cells.
    Zhang H; Borman HD; Myhr BC
    Mutat Res; 2004 Apr; 548(1-2):1-7. PubMed ID: 15063130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive protocol for conducting the Syrian hamster embryo cell transformation assay at pH 6.70.
    Kerckaert GA; Isfort RJ; Carr GJ; Aardema MJ; LeBoeuf RA
    Mutat Res; 1996 Sep; 356(1):65-84. PubMed ID: 8841475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the predictiveness of the Syrian hamster embryo cell transformation assay for determining the rodent carcinogenic potential of single ring aromatic/nitroaromatic amine compounds.
    Kerckaert GA; LeBoeuf RA; Isfort RJ
    Toxicol Sci; 1998 Feb; 41(2):189-97. PubMed ID: 9520355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalidation study of the Syrian hamster embryo (SHE) cell transformation assay at pH 7.0 for assessment of carcinogenic potential of chemicals.
    Maire MA; Pant K; Poth A; Schwind KR; Rast C; Bruce SW; Sly JE; Kunz-Bohnenberger S; Kunkelmann T; Engelhardt G; Schulz M; Vasseur P
    Mutat Res; 2012 Apr; 744(1):64-75. PubMed ID: 22227405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalidation study of the Syrian hamster embryo (SHE) cell transformation assay at pH 6.7 for assessment of carcinogenic potential of chemicals.
    Pant K; Bruce SW; Sly JE; Kunkelmann T; Kunz-Bohnenberger S; Poth A; Engelhardt G; Schulz M; Schwind KR
    Mutat Res; 2012 Apr; 744(1):54-63. PubMed ID: 22178964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological transformation of Syrian hamster embryo cells at pH 6.7 by bemitradine, a nongenotoxic carcinogen.
    Oshiro Y; Balwierz PS; Morris DL; Alden CL; Bunch RT
    In Vitr Mol Toxicol; 2001; 14(2):121-7. PubMed ID: 11690565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the Syrian hamster embryo cell transformation assay for determining the carcinogenic potential of heavy metal compounds.
    Kerckaert GA; LeBoeuf RA; Isfort RJ
    Fundam Appl Toxicol; 1996 Nov; 34(1):67-72. PubMed ID: 8937893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miniaturization of cytotoxicity tests for concentration range-finding studies prior to conducting the pH 6.7 Syrian hamster embryo cell-transformation assay.
    Plöttner S; Käfferlein HU; Brüning T
    Mutat Res; 2013 Aug; 755(2):108-14. PubMed ID: 23830925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of cell transformation in the Syrian hamster embryo (SHE) cell transformation system.
    Isfort RJ
    Ann N Y Acad Sci; 2000; 919():86-96. PubMed ID: 11083101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing of known carcinogens and noncarcinogens in the Syrian hamster embryo (SHE) micronucleus test in vitro; correlations with in vivo micronucleus formation and cell transformation.
    Fritzenschaf H; Kohlpoth M; Rusche B; Schiffmann D
    Mutat Res; 1993 Sep; 319(1):47-53. PubMed ID: 7690458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OECD Detailed Review Paper (DRP) number 31 on "Cell Transformation Assays for Detection of Chemical Carcinogens": main results and conclusions.
    Vasseur P; Lasne C
    Mutat Res; 2012 Apr; 744(1):8-11. PubMed ID: 22120692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommended protocol for the Syrian hamster embryo (SHE) cell transformation assay.
    Maire MA; Pant K; Phrakonkham P; Poth A; Schwind KR; Rast C; Bruce SW; Sly JE; Bohnenberger S; Kunkelmann T; Schulz M; Vasseur P
    Mutat Res; 2012 Apr; 744(1):76-81. PubMed ID: 22198328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.